Identification of distinct subgroups of EBV-positive post-transplant diffuse large B-cell lymphoma

Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review

(2015) Rosalba Camicia et al.   Molecular Cancer

Radiotherapy is the best treatment method in post transplant lymphoproliferative disorders localizing in brain: A review of the literature

(2015) Morteza Izadi et al.   Annals of Transplantation

Gene expression profiling of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly reveals alterations of characteristic oncogenetic pathways

(2014) Harumi Kato et al.   CANCER SCIENCE

In vivo intratumoral Epstein–Barr virus replication is associated with XBP1 activation and early-onset post-transplant lymphoproliferative disorders with prognostic implications

(2014) Blanca Gonzalez-Farre et al.   MODERN PATHOLOGY

The Meaning and Relevance of B-Cell Receptor Structure and Function in Chronic Lymphocytic Leukemia

(2014) Freda K. Stevenson et al.   SEMINARS IN HEMATOLOGY

A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival

(2013) Amelie Kinch et al.   ACTA ONCOLOGICA

Gene Expression Profiling Reveals Clear Differences Between EBV-Positive and EBV-Negative Posttransplant Lymphoproliferative Disorders

(2013) J. Morscio et al.   AMERICAN JOURNAL OF TRANSPLANTATION

PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies

(2013) B. J. Chen et al.   CLINICAL CANCER RESEARCH

Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors

(2013) Daan Dierickx et al.   LEUKEMIA & LYMPHOMA

Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy

(2012) M. R. Green et al.   CLINICAL CANCER RESEARCH

Bortezomib induction of C/EBP  mediates Epstein-Barr virus lytic activation in Burkitt lymphoma

(2011) C. M. Shirley et al.   BLOOD

Endoplasmic reticulum stress causes EBV lytic replication

(2011) G. M. Taylor et al.   BLOOD

Predictors of outcome in post-transplant lymphoproliferative disorder: an evaluation of tumor infiltrating lymphocytes in the context of clinical factors

(2010) Bill G. Richendollar et al.   LEUKEMIA & LYMPHOMA

EBV Zta protein induces the expression of interleukin-13, promoting the proliferation of EBV-infected B cells and lymphoblastoid cell lines

(2009) S.-C. Tsai et al.   BLOOD

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

(2009) O. Landgren et al.   BLOOD

Lymphoma After Solid Organ Transplantation: Risk, Response to Therapy, and Survival at a Transplantation Center

(2009) Jason S. Knight et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients

(2009) Daniela Capello et al.   JOURNAL OF PATHOLOGY

BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgVH unmutated chronic lymphocytic leukemia (CLL) cells

(2008) A. Guarini et al.   BLOOD

Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome

(2008) B. Chetaille et al.   BLOOD

Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology

(2008) Efsevia Vakiani et al.   HEMATOLOGICAL ONCOLOGY